Ulti_1170x120_5-11-20

PCMA

PCMA: Finalizing ‘Rebate Rule’ will increase premiums, taxpayer cost

PCMA: Finalizing ‘Rebate Rule’ will increase premiums, taxpayer cost

WASHINGTON— Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration and Health and Human Services (HHS) Secretary Alex Azar finalizing the rebate rule (Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection): “Simply put, the HHS Secretary’s

PCMA issues statement on 2020 election results

PCMA issues statement on 2020 election results

WASHINGTON — PCMA president and CEO JC Scott issued the following statement on the 2020 presidential election: “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs) congratulates the President-elect and looks forward to working with the new Administration on lowering prescription drug costs for all Americans. “We appreciate the stated focus of the

New report confirms proposed “rebate rule” would raise Medicare premiums and taxpayer costs

New report confirms proposed “rebate rule” would raise Medicare premiums and taxpayer costs

WASHINGTON — A new report, “Negative Economic Impact of Restricting Rebates in Medicare Part D,” by Alex Brill of Matrix Global Advisors (MGA), examines recent evidence showing that prescription drug rebates negotiated by pharmacy benefit managers (PBMs) reduce drug costs and lower premiums in Medicare Part D. The paper concludes that proposed government action to

PCMA issues statement on the ‘counteroffer’ by drug companies to the administration

PCMA issues statement on the ‘counteroffer’ by drug companies to the administration

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices and are as eager as anyone to see more progress, as reported, the ‘counteroffer’ that has

PCMA launches new ad campaign on President Trump’s executive order to revive the so-called rebate rule

PCMA launches new ad campaign on President Trump’s executive order to revive the so-called rebate rule

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of a TV and digital advertising campaign on President Trump’s Executive Order to revive the so-called rebate rule. The campaign warns policymakers and the public that the Administration’s plan will drastically increase Medicare premiums for America’s seniors and most vulnerable. Click here to view the

America’s prescription drug supply chain stands together

America’s prescription drug supply chain stands together

WASHINGTON —  On Thursday, members of the prescription drug supply and payment chain, including pharmacy benefit managers (PBMs), pharmaceutical manufacturers, pharmacies, including specialty and managed care pharmacies, and health plans, sent a letter to Vice President Mike Pence and congressional leaders affirming the safety and resiliency of the drug supply chain, and calling for public-private

PCMA adds Asher to board, Lotvin named chairman

PCMA adds Asher to board, Lotvin named chairman

WASHINGTON— The Pharmaceutical Care Management Association (PCMA) announced that Drew Asher will be joining PCMA’s board of directors. He is the chief executive officer of Envolve Pharmacy Solutions. PCMA is the national association representing America’s pharmacy benefit managers (PBMs) which administer prescription drug plans for more than 266 million Americans with health coverage through Fortune

PCMA names new staff addition to state affairs

PCMA names new staff addition to state affairs

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both

New research: PBMs save $962 per person annually

New research: PBMs save $962 per person annually

WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices

PCMA expands staff

PCMA expands staff

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) Thursday announced staff additions to its Federal Affairs, State Affairs, Strategic Communications, and Industry Relations departments. Jocelyn Wiles has been named senior director of federal affairs. Prior to coming to PCMA, she spent five years working for America’s Essential Hospitals as a federal lobbyist. She has also worked

PCMA issues statement on proposed Rx drug rebate rule  

PCMA issues statement on proposed Rx drug rebate rule  

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Americans. There is still a problem of affordability for consumers that

PBMs support increased transparency in prescription drug supply chain

PBMs support increased transparency in prescription drug supply chain

WASHINGTON — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug prices, the Pharmaceutical Care Management Association (PCMA) is confirming its principles on transparency in the prescription drug supply chain. PCMA commends the Subcommittee’s work to bring more transparency to drug prices. America’s pharmacy benefit managers (PBMs) support greater

PCMA makes statement on the administration’s Medicare Part D Rule

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott issued the following statement on the Administration’s final Medicare Part D rule: “We share the administration’s goal of reducing prescription drug costs in Medicare. We are pleased with the administration’s thoughtful approach to overseeing price concessions negotiated between pharmacies and PBMs that are

PCMA issues statement on prescription drug rebate legislation

PCMA issues statement on prescription drug rebate legislation

WASHINGTON — Pharmaceutical Care Management president and chief executive officer J.C. Scott issued the following statement on newly introduced legislation by Senator Mike Braun (R, Ind.), “The Drug Price Transparency Act:” “We stand ready to work with Senator Braun and other policymakers who share the goal of reducing high drug costs. Pharmacy benefit managers (PBMs) are the